Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsers”

15 trials

Showing 15 of 15 results

Large-scale testing (Phase 3)Study completedNCT00538811
What this trial is testing

Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders

Who this might be right for
Hepatitis CGenotype 3Non-responders+1 more
Aga Khan University 40
Not applicableStudy completedNCT01310205
What this trial is testing

Extension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCV

Who this might be right for
Chronic Hepatitis C
SciClone Pharmaceuticals 12
Testing effectiveness (Phase 2)Study completedNCT01185028
What this trial is testing

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

Who this might be right for
Hepatitis C InfectionHIV Infection
National Institutes of Health Clinical Center (CC) 8
Early research (Phase 1)Study completedNCT00128271
What this trial is testing

Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Peregrine Pharmaceuticals 32
Early research (Phase 1)WithdrawnNCT00255359
What this trial is testing

Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers

Who this might be right for
Chronic Hepatitis C Virus Infection
Hadassah Medical Organization 60
Post-approval studies (Phase 4)Study completedNCT00207402
What this trial is testing

Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin

Who this might be right for
Hepatitis C
Brooke Army Medical Center 34
Not applicableStudy completedNCT00005687
What this trial is testing

Recycling Attempters and Relapsers in Smoking Cessation

Who this might be right for
Cardiovascular DiseasesHeart DiseasesLung Diseases
National Heart, Lung, and Blood Institute (NHLBI)
Large-scale testing (Phase 3)WithdrawnNCT01517308
What this trial is testing

24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C

Who this might be right for
Chronic Hepatitis C
Federico II University
Very early researchEnded earlyNCT00882193
What this trial is testing

Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers

Who this might be right for
Chronic Hepatitis CGenotype 1Relapse
University of Nebraska 2
Post-approval studies (Phase 4)Study completedNCT00530972
What this trial is testing

Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies

Who this might be right for
Chronic Hepatitis CHIV Infections
Hospital Carlos III, Madrid 50
Large-scale testing (Phase 3)Study completedNCT01718158
What this trial is testing

Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 444
Testing effectiveness (Phase 2)Study completedNCT01183169
What this trial is testing

Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment

Who this might be right for
Hepatitis C
Debiopharm International SA 459
Large-scale testing (Phase 3)Study completedNCT01718145
What this trial is testing

A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects

Who this might be right for
Hepatitis C Virus Infection
Bristol-Myers Squibb 258
Large-scale testing (Phase 3)Study completedNCT01741545
What this trial is testing

Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 71
Testing effectiveness (Phase 2)Study completedNCT00968357
What this trial is testing

Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed

Who this might be right for
Chronic Hepatitis C
SciClone Pharmaceuticals 40

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation